{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T16:50:58Z","timestamp":1783529458955,"version":"3.55.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:00:00Z","timestamp":1769040000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"vor","delay-in-days":21,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-36583-2","type":"journal-article","created":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T06:03:06Z","timestamp":1769061786000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["\u200cCT image-derived radiomics predicts molecular subtypes in bladder urothelial carcinoma: validation of a non-invasive classification strategy"],"prefix":"10.1038","volume":"16","author":[{"given":"Qiang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangming","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yupeng","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuqin","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jishan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,22]]},"reference":[{"issue":"1","key":"36583_CR1","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/s41572-023-00468-9","volume":"9","author":"L Dyrskjot","year":"2023","unstructured":"Dyrskjot, L. et al. Bladder cancer. Nat. Rev. Dis. Primers. 9 (1), 58 (2023).","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"1","key":"36583_CR2","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.urolonc.2020.08.023","volume":"39","author":"M Kardoust Parizi","year":"2021","unstructured":"Kardoust Parizi, M., Margulis, V., Compe Rat, E. & Shariat, S. F. The value and limitations of urothelial bladder carcinoma molecular classifications to predict oncological outcomes and cancer treatment response: A systematic review and meta-analysis. Urol. Oncol. 39 (1), 15\u201333 (2021).","journal-title":"Urol. Oncol."},{"issue":"7","key":"36583_CR3","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/s41585-023-00847-7","volume":"21","author":"CC Guo","year":"2024","unstructured":"Guo, C. C. et al. Molecular profile of bladder cancer progression to clinically aggressive subtypes. Nat. Rev. Urol. 21 (7), 391\u2013405 (2024).","journal-title":"Nat. Rev. Urol."},{"issue":"8","key":"36583_CR4","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.crad.2021.03.001","volume":"76","author":"SJ Choi","year":"2021","unstructured":"Choi, S. J. et al. Radiomics-based model for predicting pathological complete response to neoadjuvant chemotherapy in muscle-invasive bladder cancer. Clin. Radiol. 76 (8), 627 (2021). e613-627 e621.","journal-title":"Clin. Radiol."},{"issue":"9","key":"36583_CR5","doi-asserted-by":"publisher","first-page":"5965","DOI":"10.1002\/mp.17288","volume":"51","author":"S Xiong","year":"2024","unstructured":"Xiong, S. et al. Machine learning-based CT radiomics enhances bladder cancer staging predictions: A comparative study of clinical, radiomics, and combined models. Med. Phys. 51 (9), 5965\u20135977 (2024).","journal-title":"Med. Phys."},{"issue":"12","key":"36583_CR6","doi-asserted-by":"publisher","first-page":"4324","DOI":"10.1007\/s00261-024-04516-0","volume":"49","author":"W Wei","year":"2024","unstructured":"Wei, W. et al. Impact of multi-parameter images obtained from dual-energy CT on radiomics to predict pathological grading of bladder urothelial carcinoma. Abdom. Radiol. (NY). 49 (12), 4324\u20134333 (2024).","journal-title":"Abdom. Radiol. (NY)"},{"issue":"15","key":"36583_CR7","doi-asserted-by":"publisher","first-page":"15868","DOI":"10.1002\/cam4.6225","volume":"12","author":"S Xiong","year":"2023","unstructured":"Xiong, S. et al. Value of the application of computed tomography-based radiomics for preoperative prediction of unfavorable pathology in initial bladder cancer. Cancer Med. 12 (15), 15868\u201315880 (2023).","journal-title":"Cancer Med."},{"key":"36583_CR8","doi-asserted-by":"publisher","first-page":"704039","DOI":"10.3389\/fonc.2021.704039","volume":"11","author":"X Xu","year":"2021","unstructured":"Xu, X. et al. Study progress of noninvasive imaging and radiomics for decoding the phenotypes and recurrence risk of bladder cancer. Front. Oncol. 11, 704039 (2021).","journal-title":"Front. Oncol."},{"key":"36583_CR9","doi-asserted-by":"crossref","unstructured":"Fan, T. W. et al. Computed tomography-based texture analysis of bladder cancer: differentiating urothelial carcinoma from micropapillary carcinoma. Abdom Radiol. (NY) (2018).","DOI":"10.1007\/s00261-018-1694-x"},{"issue":"10","key":"36583_CR10","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s11912-018-0727-5","volume":"20","author":"DJ McConkey","year":"2018","unstructured":"McConkey, D. J. & Choi, W. Molecular subtypes of bladder cancer. Curr. Oncol. Rep. 20 (10), 77 (2018).","journal-title":"Curr. Oncol. Rep."},{"issue":"5","key":"36583_CR11","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1369\/00221554221095530","volume":"70","author":"CSC Hardy","year":"2022","unstructured":"Hardy, C. S. C. et al. Immunohistochemical assays for bladder cancer molecular subtyping: optimizing parsimony and performance of Lund taxonomy classifiers. J. Histochem. Cytochem. 70 (5), 357\u2013375 (2022).","journal-title":"J. Histochem. Cytochem."},{"issue":"1","key":"36583_CR12","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13000-025-01603-8","volume":"20","author":"R Vaithegi","year":"2025","unstructured":"Vaithegi, R. et al. Clinicopathological study and molecular subtyping of muscle-invasive bladder cancer (MIBC) using dual immunohistochemical (IHC) markers. Diagn. Pathol. 20 (1), 10 (2025).","journal-title":"Diagn. Pathol."},{"issue":"3","key":"36583_CR13","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s00428-019-02618-5","volume":"475","author":"MDC Rodriguez Pena","year":"2019","unstructured":"Rodriguez Pena, M. D. C. et al. Immunohistochemical assessment of basal and luminal markers in non-muscle invasive urothelial carcinoma of bladder. Virchows Arch. 475 (3), 349\u2013356 (2019).","journal-title":"Virchows Arch."},{"key":"36583_CR14","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.ebiom.2016.08.036","volume":"12","author":"V Dadhania","year":"2016","unstructured":"Dadhania, V. et al. Meta-Analysis of the luminal and basal subtypes of bladder cancer and the identification of signature immunohistochemical markers for clinical use. EBioMedicine 12, 105\u2013117 (2016).","journal-title":"EBioMedicine"},{"issue":"4","key":"36583_CR15","doi-asserted-by":"publisher","first-page":"832","DOI":"10.4103\/ijpm.ijpm_95_21","volume":"65","author":"G Gupta","year":"2022","unstructured":"Gupta, G. et al. Molecular stratification of high-grade urothelial carcinoma by immunohistochemistry with its histomorphological and clinical correlation. Indian J. Pathol. Microbiol. 65 (4), 832\u2013838 (2022).","journal-title":"Indian J. Pathol. Microbiol."},{"key":"36583_CR16","doi-asserted-by":"crossref","unstructured":"Sanguedolce, F. et al. Clinicopathological features and survival analysis in molecular subtypes of Muscle-Invasive bladder cancer. Int J. Mol. Sci; 24(7):6610\u20136623. (2023).","DOI":"10.3390\/ijms24076610"},{"key":"36583_CR17","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.euros.2024.12.009","volume":"73","author":"JJ de Jong","year":"2025","unstructured":"de Jong, J. J. et al. Molecular subtyping for predicting pathological upstaging and survival outcomes in clinically Organ-confined bladder cancer patients undergoing radical cystectomy. Eur. Urol. Open. Sci. 73, 24\u201330 (2025).","journal-title":"Eur. Urol. Open. Sci."},{"issue":"3","key":"36583_CR18","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1093\/jjco\/hyaa219","volume":"51","author":"J Lu","year":"2021","unstructured":"Lu, J. et al. Impact of immunohistochemistry-based molecular subtype on predicting chemotherapy response and survival in patients with T1 stage bladder cancer after bladder-preserving treatment. Jpn J. Clin. Oncol. 51 (3), 424\u2013433 (2021).","journal-title":"Jpn J. Clin. Oncol."},{"key":"36583_CR19","doi-asserted-by":"crossref","unstructured":"Goutas, D. et al. Immunohistochemical study of bladder cancer molecular subtypes and their association with PD-L1 expression. Cancers (Basel); 15(1):188\u2013201. (2022).","DOI":"10.3390\/cancers15010188"},{"issue":"6","key":"36583_CR20","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1007\/s00261-024-04265-0","volume":"49","author":"J Xue","year":"2024","unstructured":"Xue, J. et al. Prognostic predictive value of urothelial carcinoma of the bladder after TURBT based on multiphase CT radiomics. Abdom. Radiol. (NY). 49 (6), 1975\u20131986 (2024).","journal-title":"Abdom. Radiol. (NY)"},{"issue":"5","key":"36583_CR21","doi-asserted-by":"publisher","first-page":"2922","DOI":"10.1097\/JS9.0000000000001194","volume":"110","author":"Z Wei","year":"2024","unstructured":"Wei, Z. et al. A CT-based deep learning model predicts overall survival in patients with muscle invasive bladder cancer after radical cystectomy: a multicenter retrospective cohort study. Int. J. Surg. 110 (5), 2922\u20132932 (2024).","journal-title":"Int. J. Surg."},{"issue":"12","key":"36583_CR22","doi-asserted-by":"publisher","first-page":"6749","DOI":"10.1007\/s00330-020-06893-8","volume":"30","author":"G Zhang","year":"2020","unstructured":"Zhang, G. et al. CT-based radiomics to predict the pathological grade of bladder cancer. Eur. Radiol. 30 (12), 6749\u20136756 (2020).","journal-title":"Eur. Radiol."},{"issue":"18","key":"36583_CR23","doi-asserted-by":"publisher","first-page":"e20093","DOI":"10.1097\/MD.0000000000020093","volume":"99","author":"Z Wang","year":"2020","unstructured":"Wang, Z. et al. Clinical value of texture analysis in differentiation of urothelial carcinoma based on multiphase computed tomography images. Med. (Baltim). 99 (18), e20093 (2020).","journal-title":"Med. (Baltim)."},{"key":"36583_CR24","doi-asserted-by":"publisher","first-page":"899897","DOI":"10.3389\/fonc.2022.899897","volume":"12","author":"J Qian","year":"2022","unstructured":"Qian, J. et al. Feasibility study on predicting recurrence risk of bladder cancer based on radiomics features of multiphase CT images. Front. Oncol. 12, 899897 (2022).","journal-title":"Front. Oncol."},{"issue":"11","key":"36583_CR25","doi-asserted-by":"publisher","first-page":"3883","DOI":"10.1007\/s00261-024-04459-6","volume":"49","author":"M Hu","year":"2024","unstructured":"Hu, M. et al. Impact of virtual monochromatic images of different low-energy levels in dual-energy CT on radiomics models for predicting muscle invasion in bladder cancer. Abdom. Radiol. (NY). 49 (11), 3883\u20133892 (2024).","journal-title":"Abdom. Radiol. (NY)"},{"issue":"23","key":"36583_CR26","doi-asserted-by":"publisher","first-page":"235048","DOI":"10.1088\/1361-6560\/abac9c","volume":"65","author":"H Wu","year":"2020","unstructured":"Wu, H. et al. Prediction of the Ki-67 marker index in hepatocellular carcinoma based on CT radiomics features. Phys. Med. Biol. 65 (23), 235048 (2020).","journal-title":"Phys. Med. Biol."},{"key":"36583_CR27","doi-asserted-by":"publisher","first-page":"1276526","DOI":"10.3389\/fonc.2024.1276526","volume":"14","author":"S Feng","year":"2024","unstructured":"Feng, S. et al. Prediction of Ki-67 expression in bladder cancer based on CT radiomics nomogram. Front. Oncol. 14, 1276526 (2024).","journal-title":"Front. Oncol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-36583-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-36583-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-36583-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T09:50:49Z","timestamp":1770889849000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-36583-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,22]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["36583"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-36583-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,22]]},"assertion":[{"value":"25 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Our study includes a clinical trial, and the study was fully approved by the Ethics Committee of the Baotou city central hospital affiliated to Inner Mongolia medical university (No. KYLL2022004).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"6016"}}